Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blocker.
作者信息
Dodd J H, Schwender C F, Conley R A, Moore J B, Ritchie D M, Fabian A C, Fenk C J, Bourcet E, Gray-Nunez Y, Kirchner T
机构信息
R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ 08869.
出版信息
Drug Des Discov. 1993;10(1):65-75.
PMID:8399994
Abstract
摘要
相似文献
1
Synthesis and biological properties of RWJ 22108, a bronchoselective calcium channel blocker.
Drug Des Discov. 1993;10(1):65-75.
2
RWJ-22108--a novel airway tissue--selective calcium channel blocker.
Agents Actions. 1993 Sep;40(1-2):57-61. doi: 10.1007/BF01976752.
3
[The effect of Ca2+ blockers on the response of respiratory tract smooth muscle to bronchoconstrictor and bronchodilator agents].
Plucne Bolesti. 1988 Jan-Jun;40(1-2):3-8.
4
Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
J Med Chem. 1998 Feb 12;41(4):509-14. doi: 10.1021/jm9704006.
5
Calcium channel blockers and smooth muscle motility in vitro.
Proc West Pharmacol Soc. 1987;30:141-3.
6
[Prostaglandin E2-induced contraction and membrane potential change in bronchial smooth muscle].
J Smooth Muscle Res. 1995 Dec;31(6):479-80.
7
Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Dan Med Bull. 1996 Dec;43(5):429-47.
8
Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
J Med Chem. 1998 May 21;41(11):1827-37. doi: 10.1021/jm970529f.
9
Experimental antiasthmatic activity of RWJ 22108: a bronchoselective calcium entry blocker.
Int Arch Allergy Immunol. 1993;100(3):274-82. doi: 10.1159/000236424.
10
In vitro effects of nifedipine on airways smooth muscle.
Agents Actions Suppl. 1983;13:151-2.
Zotero 插件